Glutathione deficiency and human immunodeficiency virus infection
Open Access
- 1 April 1992
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 339 (8798) , 909-912
- https://doi.org/10.1016/0140-6736(92)90939-z
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acidPublished by Elsevier ,2003
- N-Acetylcysteine: A New Approach to Anti-HIV TherapyAIDS Research and Human Retroviruses, 1992
- Selective Depletion in HIV Infection of T Cells that Bear Specific T Cell Receptor V β SequencesScience, 1991
- CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progressesInternational Immunology, 1991
- N-Acetylcysteine Inhibits Latent HIV Expression in Chronically Infected CellsAIDS Research and Human Retroviruses, 1991
- Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms.The Journal of Experimental Medicine, 1990
- SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALSThe Lancet, 1989
- Low Concentrations of Acid-Soluble Thiol (Cysteine) in the Blood Plasma of HIV-1-Infected PatientsBiological Chemistry Hoppe-Seyler, 1989
- Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen OverdoseNew England Journal of Medicine, 1988
- An inducible transcription factor activates expression of human immunodeficiency virus in T cellsNature, 1987